Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÇϺΠȣÈí±âÀÇ Ä§»ùÇü¾ÏÁ¾°ú Æó »ù¾ÏÁ¾¿¡¼­ Thyroid Transcription Factor-1ÀÇ ¹ßÇö Expression of the Thyroid Transcription Factor-1 in Carcinomas of Salivary Gland Type and Pulmonary Adenocarcinomas

´ëÇѺ´¸®ÇÐȸÁö 2003³â 37±Ç 3È£ p.180 ~ 185
ÃÖÁ¾¼ø, ¼­Á¤¿í, ¼­Áø¿ø, ÇÑÁ¤È£,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÁ¾¼ø ( Choi Jong-Sun ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø º´¸®Çб³½Ç

¼­Á¤¿í ( Seo Jeong-Wook ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼­Áø¿ø ( Seo Jin-Won ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø º´¸®Çб³½Ç
ÇÑÁ¤È£ ( Han Joung-Ho ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø º´¸®Çб³½Ç

Abstract


Background: Carcinomas of salivary gland type (CSGT) in the low respiratory tract are rare and often difficult to differentiate from pulmonary adenocarcinomas, which are more common and more aggressive than CSGT, especially in the biopsy specimens. Thyroid transcription factor-1 (TTF-1) is a tissue-specific transcription factor expressed in the thyroid gland and the lung. The purpose of this study is to elucidate the diagnostic utility of TTF-1 in discerning CSGT from adenocarcinomas in the low respiratory tract.

Methods: Immunohistochemical expression of TTF-1 was investigated in 14 CSGT (9 mucoepidermoid carcinomas and 5 adenoid cystic carcinomas) and 19 adenocarcinomas (5 well differentiated, 12 moderately differentiated and 2 poorly differentiated).

Results: Normal alveolar cells as well as bronchial epithelial cells showed the immunoreactivity for TTF-1, but not in the bronchial glands. In tumors, immunoreactivity for TTF-1 was identified in 17 out of 19 cases of adenocarcinomas (89%), but in none of 14 cases of CSGT. In adenocarcinomas, the immunoreactivity for TTF-1 was strongly correlated with the degree of differentiation (p<0.001).

Conclusion: These results suggest that TTF-1 can be a valuable marker in distinguishing CSGT from adenocarcinomas of the low respiratory tract.

Å°¿öµå

Thyroid Transcription Factor-1;Carcinomas of Salivary;Gand Type;Mucoepidermoid Carcinoma;Adenoid Cystic Carcinoma;Adenocarcinoma

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS